Predict your next investment

Venture Capital
phytopartners.com

See what CB Insights has to offer

Investments

31

Portfolio Exits

3

Funds

5

About Phyto Partners

Phyto Partners is a venture capital fund that invests in businesses that operate in and around the cannabis industry.

Phyto Partners Headquarter Location

2080 NW Boca Raton Blvd Suite 6

Boca Raton, Florida, 33431,

United States

561-542-6090

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Phyto Partners News

Digital health news, funding roundup in the prior week; April 25, 2022

Apr 25, 2022

Mount Sinai's new fund; DOJ appealed lifting of mask mandate; Amwell expanded to MSK and dermatology Top Health News Mount Sinai Innovation Partners (MSIP), the commercialization arm of the Mount Sinai Health System in New York, launched i3 Prism, a technology commercialization fund focused on women and Black, Indigenous and people of color (BIPOC) health care innovators. Participating innovators can receive up to $33,000 in funding, based on their work’s milestone achievements, in an effort to bring innovations to life and improve health and well-being for all people. The U.S. Department of Health and Human Services announced the availability of nearly $90 million in American Rescue Plan funding to support new data-driven efforts for HRSA Health Center Program-supported health centers and look-alikes to identify and reduce health disparities. The data collection and reporting initiative, called Uniform Data System Patient-Level Submission, is designed to collect more and better data on social determinants of health, while also streamlining and improving data quality reporting for health centers. Emeritus, a microlearning platform with a library of over 5,000 lessons, launched Emeritus Healthcare. In partnership with world-class universities including Emory Executive Education, Columbia Business School and MIT xPRO, Emeritus Healthcare will offer a healthcare workforce development curriculum to address the global shortage. Initial offerings will include Chief Medical Officer and Chief Nursing Officer programs. Amwell announced the expansion of its virtual specialty provider and clinical program portfolio by adding Amwell Musculoskeletal and Dermatology programs. These new programs are designed to address some of the most pervasive and costly areas of healthcare and are part of Amwell efforts to enable health plans to better care for members across a wide breadth of specialty care areas and provide a holistic member experience. Phyto Partners, a venture capital fund, launched its fourth private equity fund, Phyto IV, LP, focused on businesses operating in and around neurowellness and brain health and the use of psychedelic compounds for the improvement of mental well-being. The Justice Department filed an appeal seeking to overturn a judge’s order that voided the federal mask mandate on planes and trains and in travel hubs. A federal judge in Florida had struck down the national mask mandate for mass transit, and the Transportation Security Administration said that it would it will no longer enforce the mask requirement. M&A Software investor Main Capital Partners acquired  a majority stake in VideoVisit, a provider of software services for virtual healthcare and online consultations Laborie, a diagnostic and therapeutic medical technology company, completed its acquisition of GI Supply, a developer of specialty endoscopy and paracentesis products for gastroenterologists, colorectal surgeons, and interventional radiologists Bonafide, a women's healthcare company focused on menopause symptoms, acquired   patented formulation of S-adenosylmethionine (SAM-e), a naturally occurring substance that is a key nutrient, widely used by the body Carbon Health, a national healthcare provider of in-person and virtual care, acquired MedPost Urgent Care’s California clinics, spanning Orange County, Palm Desert, and Paso Robles Quipt, a home medical equipment company focused on end-to-end respiratory care, acquired Good Night Medical, a sleep medicine and home ventilation company Fulgent Genetics, a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, entered into a definitive agreement to acquire Inform Diagnostics, an independent pathology laboratory Blackrock Neurotech, an implantable brain-computer interface technology, acquired spatial computing software firm MindX ArchiMed, an investment firm focused exclusively on the healthcare industry, entered into a definitive agreement to acquire Natus Medical Incorporated, a provider of medical device solutions to screen, diagnose, and treat disorders affecting the brain, neural pathways, and eight sensory nervous systems Core Health & Fitness, a global manufacturer of fitness equipment, acquired  digital fitness company Wexer Hikma Pharmaceuticals, a multinational pharmaceutical company, completed its acquisition of Custopharm, a generic injectable drug services company Wallaby Medical, a medical technology company focused on developing and commercializing neurovascular interventional products for treating stroke, acquired phenox GmbH, a developer of neurovascular devices for the interventional treatment of strokes Infab, producers of radiation protection aprons and accessories, acquired the division of International Biomedical that produces gloves designed to reduce the amount of radiation exposure during surgical procedures quip, a designer of personal oral care products and professional dental care services through a digital platform, acquired Toothpic, a provider of teledental services  Synergy Health Partners, a hospital services company that improves access to patient care through custom orthopedic and general surgeon staffing programs, acquired anesthesiology provider SoCal Anesthesia Solutions Funding Roundup

Phyto Partners Investments

31 Investments

Phyto Partners has made 31 investments. Their latest investment was in Willow Industries as part of their Series A on February 2, 2022.

CBI Logo

Phyto Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

2/24/2022

Series A

Willow Industries

$2M

Yes

2

1/13/2022

Series B

Vangst

$19M

No

17

11/8/2021

Series C

Fyllo

$40M

No

19

3/4/2021

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

8/12/2020

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

2/24/2022

1/13/2022

11/8/2021

3/4/2021

8/12/2020

Round

Series A

Series B

Series C

Seed VC

Series A - II

Company

Willow Industries

Vangst

Fyllo

Subscribe to see more

Subscribe to see more

Amount

$2M

$19M

$40M

$99M

$99M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

17

19

10

10

Phyto Partners Portfolio Exits

3 Portfolio Exits

Phyto Partners has 3 portfolio exits. Their latest portfolio exit was Steep Hill on January 31, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

1/31/2022

Acquired

$99M

1

1/17/2020

Acquired - II

Subscribe to see more

$99M

Subscribe to see more

10

5/15/2018

Merger

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/31/2022

1/17/2020

5/15/2018

Exit

Acquired

Acquired - II

Merger

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

1

10

10

Phyto Partners Fund History

5 Fund Histories

Phyto Partners has 5 funds, including Phyto Partners II.

Closing Date

Fund

Fund Type

Status

Amount

Sources

7/17/2018

Phyto Partners II

Multi-Stage Venture Capital

Closed

$2M

1

6/7/2018

Phyto II

$99M

10

6/23/2015

Phyto Partners I

Subscribe to see more

Subscribe to see more

$99M

10

Phyto III

$99M

10

Phyto Partners III

Subscribe to see more

Subscribe to see more

10

Closing Date

7/17/2018

6/7/2018

6/23/2015

Fund

Phyto Partners II

Phyto II

Phyto Partners I

Phyto III

Phyto Partners III

Fund Type

Multi-Stage Venture Capital

Subscribe to see more

Subscribe to see more

Status

Closed

Subscribe to see more

Subscribe to see more

Amount

$2M

$99M

$99M

$99M

Sources

1

10

10

10

10

Phyto Partners Team

3 Team Members

Phyto Partners has 3 team members, including current Managing Partner, Larry Schnurmacher.

Name

Work History

Title

Status

Larry Schnurmacher

Managing Partner

Current

Brett Finkelstein

Managing Director

Current

Brett Finklestein

Managing Director

Current

Name

Larry Schnurmacher

Brett Finkelstein

Brett Finklestein

Work History

Title

Managing Partner

Managing Director

Managing Director

Status

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.